
Plug and Play Abu Dhabi Health & Longevity Program
Abu Dhabi Innovation in Health
Plug and Play Abu Dhabi’s second accelerator program is focused on supporting the healthcare ecosystem in the MENA region. The program supports healthcare startups by connecting them to networks of corporate partners and investors to test and implement their technologies in the region, as well as improve the quality of healthcare delivered in Abu Dhabi and the UAE.
Globally, our Health innovation platform has accelerated over 100 startups in partnership with more than 20 corporations, operating in over five major cities across the globe.
Our Health Partners in Abu Dhabi
Health & Longevity Innovation
Our Focus Areas
- • Agentic AI systems increasingly handle multi-step administrative workflows end-to-end, like coordinating referrals or chasing down missing records, without a human triggering each step
- • Natural language processing pulls structured data out of physician notes and scanned records, cutting the manual chart review that used to take hours down to minutes
- • Predictive scheduling algorithms flag likely no-shows and rebalance appointment slots in real time, keeping exam rooms and equipment in use instead of sitting empty
- • AI-assisted imaging triage flags urgent scans (like a possible stroke or fracture) so radiologists review the most critical cases first
- • AI-driven risk-stratification models flag patients likely to be readmitted or to disengage from treatment, so care managers can prioritize outreach to the people who need it most
- • Remote monitoring tools like connected blood pressure cuffs and insulin pens flag out-of-range readings so care teams can intervene before a routine issue becomes an ER visit
- • Smart pill bottles and dispensers track whether doses were actually taken, and send reminders or alerts to caregivers when a patient falls behind on a regimen
- • Zero-trust architecture paired with AI-driven anomaly detection catches intrusions in real time, closing the gap that let past ransomware attacks shut down entire hospital systems for days
- • Encrypted data-sharing protocols let providers, payers, and pharma exchange patient data for research or care coordination without exposing identifiable records
- • Automated compliance tools track HIPAA and state privacy requirements across systems, flagging gaps before an audit instead of after a breach
- • Mobile health units and telehealth kiosks bring screenings and specialist consultations directly to rural communities that lack a nearby hospital or specialty clinic
- • Sliding-scale and value-based care models extend access to advanced treatments (like cell and gene therapies) for patients who couldn't otherwise afford them
- • Multilingual, AI-translated digital health tools reduce the gap in care quality and outcomes across diverse patient populations
- • Mining claims and EHR data to identify and geographically map rare disease populations, speeding up patient identification for treatments that would otherwise take years to find eligible patients
- • Machine learning models that flag likely trial candidates and referral patterns, cutting clinical trial recruitment timelines and reducing screen failure rates
- • Segmenting HCP and patient populations by prescribing behavior and disease markers to sharpen targeting for marketing and commercial launch strategies
- • FHIR-based APIs let a patient's records move seamlessly between hospitals, specialists, and payers, cutting the duplicate tests and delays caused by systems that can't talk to each other
- • Agentic AI is starting to handle prior authorization end-to-end, gathering documentation and submitting requests, cutting approval timelines from weeks to days
- • Risk-sharing and bundled payment models tied to outcomes data give providers a financial incentive to keep patients healthy, not just to deliver more billable services
- • Wearables and at-home biomarker tests, paired with AI-driven trend analysis, allowing end users to track things like sleep, glucose, and heart rate variability to add healthy years, not just lifespan
- • Genetic screening and imaging AI catch conditions like cancer or heart disease years before symptoms appear, when treatment is most effective
- • Apps and patient portals use AI to translate lab results and treatment options into plain language, so people can make decisions alongside their doctor instead of waiting to be told what to do
- • Wearables, such as continuous glucose monitors and smartwatches, feed real-time vitals to care teams, turning data into early alerts instead of a once-a-year snapshot at the doctor's office
- • Generative AI models design novel drug candidates and predict protein structures computationally
- • Cloud labs and robotic "self-driving" experimentation platforms run thousands of parallel assays overnight, turning benchwork that once took a research team months into an automated feedback loop
- • AI scientists analyze experiment data and suggest hypotheses
- • Multi-omics data (genomic, proteomic, metabolomic) combined with machine learning identifies novel disease targets and biomarkers that single-dataset analysis would miss
- • Digital twins and in-silico trial simulations model how a drug or therapy behaves in virtual patient populations, helping deprioritize failing candidates before costly human trials begin
- • Video visits and asynchronous messaging let patients in rural or underserved areas consult specialists without a multi-hour drive to the nearest major medical center
- • Remote patient monitoring links home devices to care teams, so a post-surgical or chronic care patient's recovery can be tracked without repeated in-person visits
- • Agentic AI assistants are starting to handle care coordination directly, like scheduling follow-ups or routing questions to the right specialist, keeping a patient's plan aligned across providers instead of fragmented
- • At-home rapid tests and connected diagnostic devices (like glucose meters and ECG monitors) return results in minutes instead of requiring a lab visit and days of waiting
- • AI-powered image analysis flags abnormalities in scans, pathology slides, and retinal images with a level of consistency that helps catch what a single reviewer might miss
AI-Powered Healthcare Infrastructure

Chronic Disease Management

Healthcare Cybersecurity & Data Privacy

Healthcare Everywhere and for Everyone

Market Insights & Patient Access

Payer/Provider Interoperability & Value-Based Care

Personalized Healthcare & Longevity Technology

Techbio

Tech-Enabled Care Coordination & Digital Diagnostics


Microbiome & Longevity: Top Startups Rewiring How We Age
The gut microbiome is one of the most powerful and potentially modifiable levers we have to influence how we age. As the link between the microbiome and longevity becomes clearer and corporate interest in the space continues to grow, our Plug and Play Ventures team in France is exploring the current landscape, from the research shaping the field to the startups, corporations, and investors turning longevity science into real-world products.
Our Latest Health & Longevity Insights

How Calgary Is Powering the Next Generation of Industrial Innovation
Katie Greenshields

10 French AI Startups to Watch in 2026, Handpicked by Leading VCs in France
Salim Laouiti

Neurotech’s 2nd Wave in 2026: When Non-Invasive Finally Meets Reality
Helena Turck
How we help our partners innovate in Health & Longevity
Real Success Stories
Our Global Events
Where you can find us
ADGM Square Al Maryah Island PO Box 111999 Abu Dhabi, UAE

Discover our global locations
We have a community of experts all over the world. We work as a bridge between Silicon Valley and the rest of the world, making innovation open to anyone, anywhere.











